APO RESEARCH · REPORT
Live Cell Encapsulation
Live cell encapsulation has long been proposed as a solution in modern medicine to many therapeutic problems. Cell encapsulation technology is used for the immobilization of cells within biocompatible and semipermeable membranes. The encapsulation of cells, instead of therapeutic products, is used to allow the delivery of molecules of interest for a longer time period as cells release these molecules of interest continuously. Furthermore, cells can be engineered for expressing the protein of interest in vivo without modifying the host’s genome. Cell encapsulation presents a significant advantage compared to protein encapsulation, as cell encapsulation allows a sustained and controlled delivery therapeutic molecules at a constant rate, thereby resulting in greater physiological concentrations.
Product & engineering
Understand the product.
Live cell encapsulation has long been proposed as a solution in modern medicine to many therapeutic problems. Cell encapsulation technology is used for the immobilization of cells within biocompatible and semipermeable membranes. The encapsulation of cells, instead of therapeutic products, is used to allow the delivery of molecules of interest for a longer time period as cells release these molecules of interest continuously. Furthermore, cells can be engineered for expressing the protein of interest in vivo without modifying the host’s genome. Cell encapsulation presents a significant advantage compared to protein encapsulation, as cell encapsulation allows a sustained and controlled delivery therapeutic molecules at a constant rate, thereby resulting in greater physiological concentrations.
The Live Cell Encapsulation industry can be broken down into several segments, Alginate, HEMA-MMA, etc.
Across the world, the major players cover BioTime, Reed Pacific, Viacyte, etc.
Selected research
Industry Research
Live Cell Encapsulation Industry Research Report 2026
Market perspective
Live cell encapsulation has long been proposed as a solution in modern medicine to many therapeutic problems. Cell encapsulation technology is used for the immobilization of cells within biocompatible and semipermeable membranes. The encapsulation of cells, instead of therapeutic products, is used to allow the delivery of molecules of interest for a longer time period as cells release these molecules of interest continuously. Furthermore, cells can be engineered for expressing the protein of interest in vivo without modifying the host’s genome. Cell encapsulation presents a significant advantage compared to protein encapsulation, as cell encapsulation allows a sustained and controlled delivery therapeutic molecules at a constant rate, thereby resulting in greater physiological concentrations.
The Live Cell Encapsulation industry can be broken down into several segments, Alginate, HEMA-MMA, etc.
Across the world, the major players cover BioTime, Reed Pacific, Viacyte, etc.
Read the full market overview
Global Live Cell Encapsulation key players include Viacyte, Inc., Living Cell Technologies Ltd., Sigilon Therapeutics, Inc, Sernova Corporation, PharmaCyte Biotech Inc, Gloriana Therapeutics, Kadimastem, Beta-O2 Technologies, Inc., Altucell, Inc., Diatranz Otsuka Ltd, etc.
Report Scope
This report quantifies the global Live Cell Encapsulation market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Live Cell Encapsulation.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Live Cell Encapsulation Market by Company
Viacyte, Inc.
Living Cell Technologies Ltd.
Sigilon Therapeutics, Inc
Sernova Corporation
PharmaCyte Biotech Inc
Gloriana Therapeutics
Kadimastem
Beta-O2 Technologies, Inc.
Altucell, Inc.
Diatranz Otsuka Ltd
Live Cell Encapsulation Segment by Type
Alginate
Chitosan
Cellulose
Others
Live Cell Encapsulation Segment by Application
Diabetes
Cancer
Epilepsy
Parkinson
Others
Live Cell Encapsulation Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Live Cell Encapsulation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Live Cell Encapsulation and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Live Cell Encapsulation.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Live Cell Encapsulation companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Alginate
- Chitosan
- Cellulose
- Others
Applications
- Diabetes
- Cancer
- Epilepsy
- Parkinson
- Others
Companies covered
- Viacyte, Inc.
- Living Cell Technologies Ltd.
- Sigilon Therapeutics, Inc
- Sernova Corporation
- PharmaCyte Biotech Inc
- Gloriana Therapeutics
- Kadimastem
- Beta-O2 Technologies, Inc.
- Altucell, Inc.
- Diatranz Otsuka Ltd
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Live Cell Encapsulation by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Alginate
- 2.2.3 Chitosan
- 2.2.4 Cellulose
- 2.2.5 Others
- 2.3 Live Cell Encapsulation by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Diabetes
- 2.3.3 Cancer
- 2.3.4 Epilepsy
- 2.3.5 Parkinson
- 2.3.6 Others
- 2.4 Assumptions and Limitations
3 Live Cell Encapsulation Breakdown Data by Type
- 3.1 Global Live Cell Encapsulation Historic Market Size by Type (2021-2026)
- 3.2 Global Live Cell Encapsulation Forecasted Market Size by Type (2027-2032)
4 Live Cell Encapsulation Breakdown Data by Application
- 4.1 Global Live Cell Encapsulation Historic Market Size by Application (2021-2026)
- 4.2 Global Live Cell Encapsulation Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Live Cell Encapsulation Market Perspective (2021-2032)
- 5.2 Global Live Cell Encapsulation Growth Trends by Region
- 5.2.1 Global Live Cell Encapsulation Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Live Cell Encapsulation Historic Market Size by Region (2021-2026)
- 5.2.3 Live Cell Encapsulation Forecasted Market Size by Region (2027-2032)
- 5.3 Live Cell Encapsulation Market Dynamics
- 5.3.1 Live Cell Encapsulation Industry Trends
- 5.3.2 Live Cell Encapsulation Market Drivers
- 5.3.3 Live Cell Encapsulation Market Challenges
- 5.3.4 Live Cell Encapsulation Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Live Cell Encapsulation Players by Revenue
- 6.1.1 Global Top Live Cell Encapsulation Players by Revenue (2021-2026)
- 6.1.2 Global Live Cell Encapsulation Revenue Market Share by Players (2021-2026)
- 6.2 Global Live Cell Encapsulation Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Live Cell Encapsulation Head Office and Area Served
- 6.4 Global Live Cell Encapsulation Players, Product Type & Application
- 6.5 Global Live Cell Encapsulation Manufacturers Established Date
- 6.6 Global Live Cell Encapsulation Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Live Cell Encapsulation Market Size (2021-2032)
- 7.2 North America Live Cell Encapsulation Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Live Cell Encapsulation Market Size by Country (2021-2026)
- 7.4 North America Live Cell Encapsulation Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Live Cell Encapsulation Market Size (2021-2032)
- 8.2 Europe Live Cell Encapsulation Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Live Cell Encapsulation Market Size by Country (2021-2026)
- 8.4 Europe Live Cell Encapsulation Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Live Cell Encapsulation Market Size (2021-2032)
- 9.2 Asia-Pacific Live Cell Encapsulation Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Live Cell Encapsulation Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Live Cell Encapsulation Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Live Cell Encapsulation Market Size (2021-2032)
- 10.2 South America Live Cell Encapsulation Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Live Cell Encapsulation Market Size by Country (2021-2026)
- 10.4 South America Live Cell Encapsulation Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Live Cell Encapsulation Market Size (2021-2032)
- 11.2 Middle East & Africa Live Cell Encapsulation Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Live Cell Encapsulation Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Live Cell Encapsulation Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Viacyte, Inc.
- 12.1.1 Viacyte, Inc. Company Information
- 12.1.2 Viacyte, Inc. Business Overview
- 12.1.3 Viacyte, Inc. Revenue in Live Cell Encapsulation Business (2021-2026)
- 12.1.4 Viacyte, Inc. Live Cell Encapsulation Product Portfolio
- 12.1.5 Viacyte, Inc. Recent Developments
- 12.2 Living Cell Technologies Ltd.
- 12.2.1 Living Cell Technologies Ltd. Company Information
- 12.2.2 Living Cell Technologies Ltd. Business Overview
- 12.2.3 Living Cell Technologies Ltd. Revenue in Live Cell Encapsulation Business (2021-2026)
- 12.2.4 Living Cell Technologies Ltd. Live Cell Encapsulation Product Portfolio
- 12.2.5 Living Cell Technologies Ltd. Recent Developments
- 12.3 Sigilon Therapeutics, Inc
- 12.3.1 Sigilon Therapeutics, Inc Company Information
- 12.3.2 Sigilon Therapeutics, Inc Business Overview
- 12.3.3 Sigilon Therapeutics, Inc Revenue in Live Cell Encapsulation Business (2021-2026)
- 12.3.4 Sigilon Therapeutics, Inc Live Cell Encapsulation Product Portfolio
- 12.3.5 Sigilon Therapeutics, Inc Recent Developments
- 12.4 Sernova Corporation
- 12.4.1 Sernova Corporation Company Information
- 12.4.2 Sernova Corporation Business Overview
- 12.4.3 Sernova Corporation Revenue in Live Cell Encapsulation Business (2021-2026)
- 12.4.4 Sernova Corporation Live Cell Encapsulation Product Portfolio
- 12.4.5 Sernova Corporation Recent Developments
- 12.5 PharmaCyte Biotech Inc
- 12.5.1 PharmaCyte Biotech Inc Company Information
- 12.5.2 PharmaCyte Biotech Inc Business Overview
- 12.5.3 PharmaCyte Biotech Inc Revenue in Live Cell Encapsulation Business (2021-2026)
- 12.5.4 PharmaCyte Biotech Inc Live Cell Encapsulation Product Portfolio
- 12.5.5 PharmaCyte Biotech Inc Recent Developments
- 12.6 Gloriana Therapeutics
- 12.6.1 Gloriana Therapeutics Company Information
- 12.6.2 Gloriana Therapeutics Business Overview
- 12.6.3 Gloriana Therapeutics Revenue in Live Cell Encapsulation Business (2021-2026)
- 12.6.4 Gloriana Therapeutics Live Cell Encapsulation Product Portfolio
- 12.6.5 Gloriana Therapeutics Recent Developments
- 12.7 Kadimastem
- 12.7.1 Kadimastem Company Information
- 12.7.2 Kadimastem Business Overview
- 12.7.3 Kadimastem Revenue in Live Cell Encapsulation Business (2021-2026)
- 12.7.4 Kadimastem Live Cell Encapsulation Product Portfolio
- 12.7.5 Kadimastem Recent Developments
- 12.8 Beta-O2 Technologies, Inc.
- 12.8.1 Beta-O2 Technologies, Inc. Company Information
- 12.8.2 Beta-O2 Technologies, Inc. Business Overview
- 12.8.3 Beta-O2 Technologies, Inc. Revenue in Live Cell Encapsulation Business (2021-2026)
- 12.8.4 Beta-O2 Technologies, Inc. Live Cell Encapsulation Product Portfolio
- 12.8.5 Beta-O2 Technologies, Inc. Recent Developments
- 12.9 Altucell, Inc.
- 12.9.1 Altucell, Inc. Company Information
- 12.9.2 Altucell, Inc. Business Overview
- 12.9.3 Altucell, Inc. Revenue in Live Cell Encapsulation Business (2021-2026)
- 12.9.4 Altucell, Inc. Live Cell Encapsulation Product Portfolio
- 12.9.5 Altucell, Inc. Recent Developments
- 12.10 Diatranz Otsuka Ltd
- 12.10.1 Diatranz Otsuka Ltd Company Information
- 12.10.2 Diatranz Otsuka Ltd Business Overview
- 12.10.3 Diatranz Otsuka Ltd Revenue in Live Cell Encapsulation Business (2021-2026)
- 12.10.4 Diatranz Otsuka Ltd Live Cell Encapsulation Product Portfolio
- 12.10.5 Diatranz Otsuka Ltd Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst